Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X1DV
|
||||
Former ID |
DNC008633
|
||||
Drug Name |
1-(1-(4'-Ethylbiphenyl-4-yl)propyl)-1H-imidazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H22N2
|
||||
Canonical SMILES |
CCC1=CC=C(C=C1)C2=CC=C(C=C2)C(CC)N3C=CN=C3
|
||||
InChI |
1S/C20H22N2/c1-3-16-5-7-17(8-6-16)18-9-11-19(12-10-18)20(4-2)22-14-13-21-15-22/h5-15,20H,3-4H2,1-2H3
|
||||
InChIKey |
QQMBOZZNCNQCSN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Superpathway of steroid hormone biosynthesis | ||||
Glucocorticoid biosynthesis | |||||
Androgen biosynthesis | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolic pathways | |||||
Ovarian steroidogenesis | |||||
Prolactin signaling pathway | |||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Steroidogenesis | |||||
Reactome | Androgen biosynthesis | ||||
Glucocorticoid biosynthesis | |||||
Endogenous sterols | |||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compounds | |||||
References | |||||
REF 1 | Bioorg Med Chem. 2008 Aug 15;16(16):7715-27. Epub 2008 Jul 9.Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17)--part II: Core rigidification and influence of substituents at the methylene bridge. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.